B

BioMark Diagnostics Inc
CNSX:BUX

Watchlist Manager
BioMark Diagnostics Inc
CNSX:BUX
Watchlist
Price: 0.5 CAD Market Closed
Market Cap: 52.5m CAD

Intrinsic Value

The intrinsic value of one BUX stock under the Base Case scenario is 0.01 CAD. Compared to the current market price of 0.5 CAD, BioMark Diagnostics Inc is Overvalued by 99%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BUX Intrinsic Value
0.01 CAD
Overvaluation 99%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation History
BioMark Diagnostics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about BUX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BUX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for BioMark Diagnostics Inc.

Explain Valuation
Compare BUX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BUX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
BioMark Diagnostics Inc

Current Assets 2.3m
Cash & Short-Term Investments 2.1m
Receivables 170k
Non-Current Assets 392.9k
Long-Term Investments 3.2k
PP&E 355.6k
Other Non-Current Assets 34.1k
Current Liabilities 1.2m
Accounts Payable 291k
Other Current Liabilities 934.1k
Non-Current Liabilities 101.1k
Long-Term Debt 101.1k
Efficiency

Free Cash Flow Analysis
BioMark Diagnostics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
BioMark Diagnostics Inc

Revenue
154.9k CAD
Operating Expenses
-2.1m CAD
Operating Income
-1.9m CAD
Other Expenses
187.3k CAD
Net Income
-1.7m CAD
Fundamental Scores

BUX Profitability Score
Profitability Due Diligence

BioMark Diagnostics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Operating Margin is Increasing
Net Margin is Increasing
Low 3Y Average Gross Margin
28/100
Profitability
Score

BioMark Diagnostics Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

BUX Solvency Score
Solvency Due Diligence

BioMark Diagnostics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
High Altman Z-Score
Long-Term Solvency
61/100
Solvency
Score

BioMark Diagnostics Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BUX Price Targets Summary
BioMark Diagnostics Inc

There are no price targets for BUX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

BioMark Diagnostics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BUX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one BUX stock?

The intrinsic value of one BUX stock under the Base Case scenario is 0.01 CAD.

Is BUX stock undervalued or overvalued?

Compared to the current market price of 0.5 CAD, BioMark Diagnostics Inc is Overvalued by 99%.

Back to Top